Summer Sale
50% off Premium Yearly
NYSE:CRBG
Corebridge Financial, Inc. (CRBG)
Financials 
Technical Analysis 
Jun 15, 2026, 12:00 amThis summary was created by AI, based on 3 opinions in the last 12 months.
Corebridge Financial, Inc. (CRBG-N) is attracting attention from multiple experts, with mixed reviews regarding its stock performance but an overall positive outlook on the business fundamentals. Despite a recent decline in stock price, the company is well-capitalized, particularly following its merger with Equitable Life, which is expected to enhance its financial standing. Analysts note the company's ability to navigate challenges in the private credit space, underlining its strong dividend and trading metrics, which suggest it is currently undervalued. While concerns exist about the life insurance sector, especially regarding investment yield amidst fluctuating interest rates, Corebridge is recognized for its prudent financial management and potential for robust earnings, projecting over $5 EPS. The company’s diversified portfolio reinforces confidence among analysts, leading to expectations of steadily improving performance moving forward.
Doesn't like the stock performance, but business doing reasonably well. Still undervalued. Steady-eddy life insurance. There are worries about the lifecos and where is their money invested. Usually when interest rates drop, yields on lifecos also drop. But insurance companies are clever about generating good returns.
Spinoff from AIG. Life insurance and retirement products. Well run. Great margin of safety. Trading at 6x forward PE. Earnings can grow quickly. Very large regulatory base of capital (RBC), well above buffers required. Serial acquires of stock, which is very accretive at this price. Yield is 3.06%.
(Analysts’ price target is $38.60)CRBG has done well, up 49% this year, yet remains very cheap at 6.7X earnings with a 2.84% yield. The recent quarter was solid with an 18% 'beat' over earnings estimates. Corebridge is well-positioned to reach consensus for double-digit EPS gains in 2025-26 given solid organic growth in its flagship individual annuities business and robust reserve gains in the institutional spread operations. Life insurance sales have also expanded, rising 14% in 3Q. In traditional fixed annuities, deposits have doubled year to date, to $9.5 billion, the surrender pace is down 5 percentage points vs. a year ago and general account assets are up 16% to $58 billion. For fixed-index annuities, the general account has increased 30% vs. 3Q23. Corebridge’s results are also benefiting from recent expense savings of about $400 million and accelerating share buybacks. The share count declined 8% in 3Q. Things continue to look very good here.
Unlock Premium - Try 5i Free
Spun out of AIG, in retirement and life insurance business. Very cheap. They've been buying back shares. They have earnings power of $5/share, so you're paying over 6x earnings (vs. MFC's 11x PE). They have excess capital on the balance sheet. Pays a 3% dividend. It benefits from higher interest rates. Is up 47% this year.
(Analysts’ price target is $34.64);fill-opacity:1;'/%3e%3cpath%20d='M31%2018.6001V30H8V18.6001L14.1334%2022.4334L19.4999%2014L24.8669%2022.4334L31%2018.6001Z'%20fill='%23EE5432'%20style='fill:%23EE5432;fill:color(display-p3%200.9340%200.3310%200.1956);fill-opacity:1;'/%3e%3c/svg%3e){kind=small}
Premium contentOur PAST TOP PICK with CRBG has triggered its stop at $19.50. To remain disciplined, we recommend covering the position at this time. This will result in a net investment gain of 6%, when combined with our previous recommendations.
Premium contentWe again reiterate CRBG as a TOP PICK. It trades at 5x earnings, 1.2x book and supports a 21% ROE. We like that cash reserves are growing, while debt is retired. It pays a nice dividend, backed by a payout ratio under 25% of cash flow. We recommend trailing up the stop (from $17.50) to $19.50, look to achieve $25 -- upside potential of 19%. Yield 4.4%
(Analysts’ price target is $24.92)Premium contentWe reiterate this US retirement and insurance provider, with over $370 billion in assets under management, as a TOP PICK. It trades at 5x earnings, 1.2x book and supports a ROE of 21%. Deposits and premiums grew over 40% over the year to almost $10 billion. Cash reserves are growing, while to company is aggressively retiring debt. It pays a good dividend, backed by a payout ratio under 25% of cash flow. We recommend trailing up the stop (from $16.50) to $17.50, looking to achieve $25.00 -- upside potential over 30%. Yield 4.8%
(Analysts’ price target is $25.08)Premium contentAs one of the largest retirement solutions providers in the US, managing over $370 billion in assets, we reiterate CRBG as a TOP PICK. Recently reported earnings revealed deposits and margins expanded over 42% each over the year. Cash reserves are growing as debt is aggressively retired. It trades at 5x earnings, 1.1x book and supports a 21% ROE. We recommend trailing up the stop (from $15.00) to $16.50, looking to achieve $24.00 -- upside potential of 23%. Yield 4.6%
(Analysts’ price target is $24.67)Premium contentWe reiterate CRBG, manager of $365 billion in financial assets, as a TOP PICK. The company announced a $0.62 special dividend to holders of record on June 16 - on top of the regular quarterly dividend of $0.23. Cash reserves are growing, while debt is aggressively retired. It trades at 1.3x book and supports a ROE of 27%. We recommend trailing up the stop (from $14) to $15, looking to achieve $24 -- upside potential of 37%. Yield 4.1%
(Analysts’ price target is $24.46)Premium contentCRBG provides annuity and insurance financial products primarily to retirees in the US. The company trades at 5x earnings, 1.3x book value and supports a ROE of 44%. Recently reported earnings for 2022 showed revenue growth of 14%, income growth of 11% and a 31% profit margin. We like that it is building cash reserves while aggressively retiring debt. We recommend a stop loss at $14, looking to achieve $24.50 -- upside potential over 50%. Yield 2.9%
(Analysts’ price target is $24.77)- «
- ‹
- 1
- ›
- »
Corebridge Financial, Inc. (CRBG) Frequently Asked Questions
What is Corebridge Financial, Inc. stock symbol?
Corebridge Financial, Inc. is a American stock, trading under the symbol CRBG (previously CRBG-N on Stockchase) on the New York Stock Exchange (CRBG). It is usually referred to as NYSE:CRBG or CRBG
Is Corebridge Financial, Inc. a buy or a sell?
In the last year, 3 stock analysts issued a Buy, Sell, or Hold rating on CRBG (previously CRBG-N on Stockchase). 3 analysts recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is TOP PICK. Read the latest stock experts' ratings for Corebridge Financial, Inc..
Is Corebridge Financial, Inc. a good investment or a top pick?
Corebridge Financial, Inc. was recommended as a Top Pick by The Panic-Proof Portfolio (Stockchase Research) on 2023-04-11. Read the latest stock experts ratings for Corebridge Financial, Inc..
Why is Corebridge Financial, Inc. stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Corebridge Financial, Inc..
Is Corebridge Financial, Inc. worth watching?
Corebridge Financial, Inc. is followed by 23 investors on Stockchase and is a trending stock that is worth watching.
What is Corebridge Financial, Inc. stock price?
On 2026-06-15, Corebridge Financial, Inc. (CRBG) stock closed at a price of $29.33.
'%20fill='%23FFB800'%3e%3cg%20id='filled-.-button'%20transform='translate(120.000000,%20413.999972)'%3e%3cpath%20d='M101.499729,2.82302245e-05%20C102.285413,-0.00432461793%20103.254164,0.496634241%20103.645655,1.25173399%20L103.712109,1.39623206%20L105.747863,6.45331817%20L111.028779,6.80428588%20C111.60867,6.84282525%20112.147242,7.1236355%20112.517275,7.58038413%20C113.223405,8.45199453%20113.142035,9.72214747%20112.357105,10.4940033%20L112.234099,10.6059323%20L108.072656,14.10894%20L109.356339,19.592529%20C109.472157,20.0872738%20109.394126,20.6085551%20109.13883,21.0455786%20C108.624329,21.9263208%20107.536956,22.2447485%20106.649713,21.8010736%20L106.511398,21.7246573%20L101.5,18.7715858%20L96.4886024,21.7246573%20C95.5790916,22.2767096%2094.4027498,21.9726757%2093.8611695,21.0455786%20C93.6058745,20.6085551%2093.5278433,20.0872738%2093.6436608,19.592529%20L94.9273443,14.10894%20L90.7659013,10.6059323%20C89.8680707,9.85015912%2089.7412886,8.49557505%2090.4827254,7.58038413%20C90.8527577,7.1236355%2091.39133,6.84282525%2091.9712215,6.80428588%20L97.2521374,6.45331817%20L99.2878908,1.39623206%20C99.6240254,0.561228427%20100.665516,-0.00460395016%20101.499729,2.82302245e-05%20Z'%20id='top-picks-.-icon-copy-7'%3e%3c/path%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e){kind=small}
Many lifecos are getting hit over exposure to the trouble private credit space. CRBG is well-financed. Last week, they said they will merge with Equitable Life, so they will become much bigger with excess capital. They pay a good dividend. Trades at 4.5-5x earnings and below book value.